December 3rd 2024.
According to a recent report, a team of Australian researchers has developed a new treatment for obesity that could potentially eliminate the side effects associated with medications like Ozempic. The treatment, known as "InuMCT", is derived from a combination of plant fiber coating called inuline and a blend of coconut and palm kernel oils. Not only does this treatment target weight loss, but it also has the potential to improve other markers of obesity such as inflammation and blood glucose levels.
The study, which was released in the journal Advanced Therapeutics, has shown promising results after a 21-day testing period. InuMCT not only reduced weight gained from a western diet, but it also lowered blood sugar levels by 15%, reduced inflammatory markers by 78%, and decreased liver enzyme levels by up to 47%. Furthermore, the treatment showed a significant increase in protective gut bacteria by 830%. These findings are crucial as Australia reports that two thirds of adults and over a quarter of children are overweight or obese, while globally one in eight people are considered obese, leading to at least 2.8 million deaths per year.
PhD researcher Amin Ariaee from the University of South Australia believes that InuMCT offers a natural and holistic approach to treating obesity. Ariaee states that "Obesity is not just about weight gain, it is a complex health problem that affects individuals in various ways." He goes on to explain that current treatments often ignore the role of the gut microbiome, which plays a crucial role in obesity and related health issues.
The team's senior researcher, Dr. Paul Joyce, suggests that combining InuMCT with other obesity treatments could have a dual effect on weight loss and long-term gut health. This is particularly important as obesity is linked to various health conditions such as cardiovascular disease, type two diabetes, stroke, kidney disease, and mental health issues. The team's approach is to address all of these symptoms rather than focusing on just one aspect such as excess weight.
The InuMCT microcapsules, which are individually smaller than a red blood cell, can be taken in the form of a tablet or capsule. The researchers are now planning to conduct further studies to explore the potential of InuMCT as an adjunct therapy in clinical settings. However, they emphasize the importance of consulting a doctor before making any major medical or dietary changes.
In conclusion, this groundbreaking research has introduced a natural and holistic approach to treating obesity and its related health issues. By utilizing food-grade ingredients, InuMCT has shown positive results in promoting a healthy gut microbiome, reducing inflammation, and aiding in weight loss. The team hopes to continue their research and potentially introduce this treatment as an adjunct therapy in clinical settings. Stay up-to-date on the latest news and developments by downloading the 9NEWS app. Remember to always consult a doctor before making any significant changes to your diet or medical treatment.
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]
